Liver Fibrosis
📧 Sign up to get email alerts when something new happens for Liver Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis. [Phase 1]
Phase 1 open-label PET study to evaluate AZD2389 FAP occupancy in the liver of participants with advanced liver fibrosis. The trial is curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B. [Phase 3]
Phase IIIc clinical trial to evaluate the long-term use of Hydronidone capsules for liver fibrosis in patients with chronic hepatitis B; sta…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls [Phase 1]
Phase 1 study of Hydroxynidone Capsules in patients with liver fibrosis and hepatic impairment; the trial is not yet recruiting and is spons…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. [NA]
A clinical trial update from Université de Sherbrooke indicates recruitment for a study testing niacin to stimulate fat storage in adipose t…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Integrated Diagnostics for Early Diagnosis of Liver Disease
This clinical trial entry reports that a study on integrated diagnostics for early detection of liver disease is currently recruiting, evalu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update on empagliflozin for liver fibrosis and cirrhosis in chronic hepatitis B with NAFLD; currently active but not …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: RTX001 Autologous Engineered Macrophages for Liver Cirrhosis [Phase 1, Phase 2]
RTX001 is an autologous engineered macrophage therapy being investigated in Phase 1/2 trials for end-stage liver disease and liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers [NA]
This study investigates signatures for detecting liver fibrosis in chronic liver disease, aiming to go beyond conventional biomarkers, and i…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
A completed clinical trial evaluating the epidemiology of hepatitis B virus in a representative sample of adults in Zambia, sponsored by the…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
This clinical trial update describes a follow-up study examining MASLD in adults with Type 2 diabetes in primary care, with enrollment by in…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI [NA]
Clinical trial update on using FibroX AI to improve primary-care diagnosis of liver fibrosis in MASLD; the study status is NOT_YET_RECRUITIN…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
A clinical trial update notes a study in pediatric patients with Glycogen storage disease type III evaluating non-invasive methods to assess…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide [Phase 1]
Phase 1 drug–drug interaction study investigating Hydronidone with entecavir and several tenofovir prodrugs in chronic hepatitis B with live…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Growth Hormone in Decompensated Liver Cirrhosis [Phase 2, Phase 3]
Clinical trial update showing completion of Phase 2 and Phase 3 studies evaluating Growth Hormone in patients with decompensated liver cirrh…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Incidence of HANA Conditions in HIV-infected Individuals
This completed clinical trial evaluated the incidence of HIV-associated non-AIDS (HANA) conditions in HIV-infected individuals, and results …
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis [NA]
A clinical trial update describes ongoing research assessing whether phycocyanin may protect against liver fibrosis and cirrhosis.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Recruitment is ongoing for a study examining screening and follow-up in patients with HIV infection and metabolic-associated fatty liver dis…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population [NA]
The study titled 'SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population' is currently recruiting and aims to s…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: The Phase Ⅰd Clinical Trial of Hydronidone Capsules [Phase 1]
Update on the Phase Id clinical trial of Hydronidone capsules for liver fibrosis; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) [NA]
This clinical trial update outlines a physiologic analysis of Endoscopic Sleeve Gastroplasty (ESG). It addresses conditions including non-al…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial [NA]
A randomized controlled trial is recruiting to evaluate endoscopic sleeve gastroplasty for obesity in patients with MASLD/MASH and related l…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography
A multicenter clinical study is evaluating a visual transient elastography method to noninvasively assess hepatic steatosis and fibrosis in …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Erlotinib for Hepatocellular Carcinoma Chemoprevention [Phase 2]
Phase 2 clinical trial evaluating erlotinib for chemoprevention of hepatocellular carcinoma in patients with cirrhosis or advanced liver fib…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis [NA]
A completed clinical trial update describing a non-invasive approach to assess hepatic fibrosis in pediatric patients. The document notes th…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD [NA]
A clinical trial comparing two non-invasive strategies to diagnose advanced liver fibrosis in non-alcoholic fatty liver disease; currently r…